Institutional investors control 12.85% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $10.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JTC PLC /PRIVATE BANKING/ Bought 7.4 Million shares of GlaxoSmithKline PLC
BNP PARIBAS ARBITRAGE SNC Bought 6.0 Million shares of GlaxoSmithKline PLC
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.8 Million shares of GlaxoSmithKline PLC